To further validate the cytokine array results, we performed immunohistochemistry staining for CCL18 in breast tumor biopsies from 259 breast cancer patients before neoadjuvant chemotherapy and correlated CCL18+ cell count with chemotherapeutic response. This evidence concerns the gene CCL18 and breast neoplasm.